{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:27:13Z","timestamp":1786991233782,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lipidjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jacl.2024.08.007","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T14:18:28Z","timestamp":1725459508000},"page":"e1046-e1054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Challenges and opportunities for identifying people with familial hypercholesterolemia in the UK: Evidence from the National FH PASS database"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8981-0699","authenticated-orcid":false,"given":"Edward","family":"Cox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Saramago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Haralambos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve E","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2024.08.007_bib0001","unstructured":"British heart foundation. Familial hypercholesterolaemia: cascade testing in the UK today. 2019;"},{"issue":"1","key":"10.1016\/j.jacl.2024.08.007_bib0002","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular riskThe Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.jacl.2024.08.007_bib0003","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ahj.2014.09.001","article-title":"Reducing the burden of disease and death from familial hypercholesterolemia: A call to action","volume":"168","author":"Knowles","year":"2014","journal-title":"Am Heart J [Internet]"},{"key":"10.1016\/j.jacl.2024.08.007_bib0004","unstructured":"NHS England \u2014 London \u00bb Familial Hypercholesterolemia (FH) [Internet]. [cited 2022 Oct 6]. Available from: https:\/\/www.england.nhs.uk\/london\/london-clinical-networks\/our-networks\/cardiac\/familial-hypercholesterolaemia\/"},{"issue":"7349","key":"10.1016\/j.jacl.2024.08.007_bib0005","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/bmj.324.7349.1303","article-title":"Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia","volume":"324","author":"Marks","year":"2002","journal-title":"BMJ [Internet]"},{"issue":"14","key":"10.1016\/j.jacl.2024.08.007_bib0006","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1136\/hrt.2010.213975","article-title":"Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies","volume":"97","author":"Nherera","year":"2011","journal-title":"Heart [Internet]."},{"issue":"23","key":"10.1016\/j.jacl.2024.08.007_bib0007","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/eurheartj\/ehx111","article-title":"Cost effectiveness of cascade testing for familial hypercholesterolaemia, based on data from familial hypercholesterolaemia services in the UK","volume":"38","author":"Kerr","year":"2017","journal-title":"Eur Heart J [Internet]"},{"key":"10.1016\/j.jacl.2024.08.007_bib0008","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.atherosclerosis.2018.05.021","article-title":"Cost-utility analysis of searching electronic health records and cascade testing to identify and diagnose familial hypercholesterolaemia in England and Wales","volume":"275","author":"Crosland","year":"2018","journal-title":"Atherosclerosis [Internet]"},{"key":"10.1016\/j.jacl.2024.08.007_bib0009","series-title":"Familial hypercholesterolaemia: identification and management - Clinical guideline [CG71]. (Last updated in 2019)","year":"2008"},{"issue":"1","key":"10.1016\/j.jacl.2024.08.007_bib0010","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.atherosclerosis.2015.03.003","article-title":"Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales","volume":"240","author":"Haralambos","year":"2015","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.jacl.2024.08.007_bib0011","article-title":"The reduced cost of providing a nationally recognised service for familial hypercholesterolaemia","volume":"1","author":"Pears","year":"2014","journal-title":"Open Heart [Internet]."},{"issue":"2","key":"10.1016\/j.jacl.2024.08.007_bib0012","article-title":"Familial hypercholesterolaemia (FH) \u2013 Finding the needle in a haystack in a Scottish population","volume":"255","author":"Gellatly","year":"2016","journal-title":"Atherosclerosis [Internet]"},{"key":"10.1016\/j.jacl.2024.08.007_bib0013","doi-asserted-by":"crossref","unstructured":"S.E. Humphries R. Challis Kdehtlcmsmaodoatbetewgn. Heart UK 2023 Moderated Posters - How many FH genetic tests were performed by the UK Genetic Laboratory Hubs in 2022? Atherosclerosis Plus. 2023;","DOI":"10.1016\/j.athplu.2023.07.005"},{"key":"10.1016\/j.jacl.2024.08.007_bib0014","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.atherosclerosis.2019.11.028","article-title":"Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies","volume":"293","author":"Wald","year":"2020","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.jacl.2024.08.007_bib0015","article-title":"A comparison of the Netherlands, Norway and UK familial hypercholesterolemia screening programmes with implications for target setting and the UK's NHS long term plan","volume":"3","author":"Page","year":"2023","journal-title":"PLOS Global Public Health [Internet]"},{"issue":"3","key":"10.1016\/j.jacl.2024.08.007_bib0016","article-title":"Using pass database and geographic information systems (GIS) to map familial hypercholesterolaemia (FH) diagnoses in England and Wales","volume":"255","author":"Kate Haralambos","year":"2016","journal-title":"Atherosclerosis [Internet]"},{"issue":"2","key":"10.1016\/j.jacl.2024.08.007_bib0017","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.gim.2021.09.012","article-title":"The Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia Variant Curation Expert Panel consensus guidelines for LDLR variant classification","volume":"24","author":"Chora","year":"2022","journal-title":"Genet Med [Internet]"},{"issue":"1","key":"10.1016\/j.jacl.2024.08.007_bib0018","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.atherosclerosis.2014.12.036","article-title":"Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: An Australian experience","volume":"239","author":"Bell","year":"2015","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.jacl.2024.08.007_bib0019","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jamacardio.2019.5173","article-title":"Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action","volume":"5","author":"Wilemon","year":"2020","journal-title":"JAMA Cardiol [Internet]"},{"key":"10.1016\/j.jacl.2024.08.007_bib0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.atherosclerosis.2018.06.011","article-title":"Latvian registry of familial hypercholesterolemia: The first report of three-year results","volume":"277","author":"Latkovskis","year":"2018","journal-title":"Atherosclerosis"},{"issue":"Pt 1","key":"10.1016\/j.jacl.2024.08.007_bib0021","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1258\/acb.2008.008094","article-title":"Family tracing to identify patients with familial hypercholesterolaemia: the second audit of the Department of Health Familial Hypercholesterolaemia Cascade Testing Project","volume":"46","author":"Hadfield","year":"2009","journal-title":"Ann Clin Biochem [Internet]"},{"issue":"4","key":"10.1016\/j.jacl.2024.08.007_bib0022","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/sj.ejhg.5201360","article-title":"Cascade testing in familial hypercholesterolaemia: how should family members be contacted?","volume":"13","author":"Newson","year":"2005","journal-title":"Eur J Hum Genet [Internet]"},{"issue":"11","key":"10.1016\/j.jacl.2024.08.007_bib0023","first-page":"506","article-title":"New case detection by cascade testing in familial hypercholesterolemia: a systematic review of the literature","volume":"12","author":"Lee","year":"2019","journal-title":"Circ Genom Precis Med [Internet]"},{"issue":"7275","key":"10.1016\/j.jacl.2024.08.007_bib0024","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1136\/bmj.321.7275.1497","article-title":"Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia","volume":"321","author":"Bhatnagar","year":"2000","journal-title":"BMJ : British Med J [Internet]."},{"key":"10.1016\/j.jacl.2024.08.007_bib0025","doi-asserted-by":"crossref","unstructured":"Marks D, Thorogood M, Neil SM, Humphries SE, Neil HAW. Cascade screening for familial hypercholesterolaemia: implications of a pilot study for national screening programmes. 101258\/096914106778440617 [Internet]. 2006 Sep 1 [cited 2023 Sep 14];13(3):156\u20139. Available from: https:\/\/journals.sagepub.com\/doi\/10.1258\/096914106778440617?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed","DOI":"10.1258\/096914106778440617"},{"issue":"9251","key":"10.1016\/j.jacl.2024.08.007_bib0026","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(00)03587-X","article-title":"Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands","volume":"357","author":"Umans-Eckenhausen","year":"2001","journal-title":"Lancet [Internet]"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287424002344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287424002344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T10:15:11Z","timestamp":1740651311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287424002344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1933287424002344"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2024.08.007","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges and opportunities for identifying people with familial hypercholesterolemia in the UK: Evidence from the National FH PASS database","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2024.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 National Lipid Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}